OVERVIEW Opko Health (NYSE:??OPK) is a mid-cap pharmaceutical stock with several corporate growth strategies: clinical drugs, medical devices, and strategic acquisitions. Of particular interest to many investors is its CEO?s systematic buyback of common stock in the open market, totaling over $23 million in buys for his personal account during the past year. Because of ...
FEEDS
